Advantage of CERo’s CER receptor lies in native human protein-based antigen binding: CEO
CERo Therapeutics Holdings, Inc. is a biotechnology company pioneering engineered T cell immunotherapies to combat cancer, with a focus on ...
Friday, June 19, 2026
Tag: human
-1024x683.jpg "Strait Outta Hormuz: Getting the Iran Oil Story Straight")
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.